After two years of equity market underperformance relative to the US and a steep slide for the Canadian dollar it’s time for investors to take another long look at the Great White North. Read More

This month’s Best Buys--Peyto Exploration & Development Corp (TSX: PEY, OTC: PEYUF) Brookfield Renewable Energy Partners LP (TSX: BEP-U, NYSE: BEP)--continue to expand their respective asset bases and build wealth for shareholders. Read More

It’s a good sign of a healthy underlying business, and it provides good protection against rising interest rates and inflation. And it’s happening a lot for CE Portfolio Holdings. Read More

The main Canadian equity benchmark has closely followed a major emerging markets index over the past five years, corresponding to a significant shift in the composition of Canada’s export markets. Read More

Two members of the How They Rate coverage universe announced payout reductions during the past month, while another won’t pay a first-quarter dividend due to the terms of a pending merger. Read More

We have a few more changes to note this month, including an addition to How They Rate coverage, another set of subtractions, some advice changes and a couple Safety Rating adjustments. Read More

A recent International Monetary Fund reports suggests further downside for the Australian dollar may be a good thing. Other data compiled by the intergovernmental agency confirm long-term investors’ respect for a currency backed by solid fundamentals. Read More

Telstra Corp Ltd (TSX: TLS, OTC: TTRAF, ADR: TLSYY) boosted its regular dividend rate by 3.6 percent, the first increase for Australia’s dominant mobile services provider in nine years. Read More

The price of iron ore is likely headed lower as China’s early 21st boom cools. But there are still opportunities for companies and investors to make money from what remains a key element of global economic growth. Read More

Analysts were underwhelmed by CSL Ltd’s (ASX: CSL, OTC: CMXHF, ADR: CMXHY) fiscal 2014 first-half results. A solid dividend increase, recent regulatory approvals and a healthy R&D pipeline suggest recent share-price weakness is a great opportunity for new investors. Read More